SYNERGISM OF ASCORBIC-ACID AND GLUTATHIONE IN THE REDUCTION OF HEXAVALENT CHROMIUM INVITRO

被引:28
|
作者
SUZUKI, Y
机构
[1] National Institute of Industrial Health, Tamaku, Kawasaki 214, 21-1
关键词
Ascorbic acid; Glutathione; Half-life; Hexavalent chromium; Reduction; Synergism;
D O I
10.2486/indhealth.28.9
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The reduction of 20 μM hexavalent chromium [chromium(VI)] in single-reductant solutions of 0.02-2 mM L-ascorbic acid (L-AsA) or 2 mM reduced glutathione (GSH), and in mixed solutions of 2 mM GSH containing L-AsA of the above-described concentrations was investigated at physiological pH (37° C). The reduction of chromium(VI) in the L-AsA solutions of higher concentrations showed pseudo-first-order kinetics in a single phase with respect to chromium(VI). In the lower L-AsA concentrations, pseudo-first-order processes appeared only in an early stage of the reaction. The reduction in the GSH solution was characterized by a two-phase process. In the first phase, which appeared in very short duration, the reaction rate was much higher than that in the second, but resulted in a decrease of only 1% of the initial chromium(VI) level. The second phase showed the main process of the reduction. This indicated pseudo-first-order kinetics. The half-life values of chromium(VI) depended on the initial levels of the reductants and ranged from seconds to hours. The chromium(VI)-reducing ability of L-AsA was markedly higher than that of GSH. In the mixed solutions of L-AsA and GSH, synergistic effect on the reduction of chromium(VI) was observed, especially in earlier stages of the processes. The synergism was more conspicuous in the mixed solutions containing lower L-AsA levels. These results suggest that although AsA possesses higher reducing ability than GSH, their coexistence is of importance for the reduction of chromium(VI) in biological systems because of their synergism. © 1990, National Institute of Occupational Safety and Health. All rights reserved.
引用
收藏
页码:9 / 19
页数:11
相关论文
共 50 条
  • [21] Experimental modeling and optimization for the reduction of hexavalent chromium in aqueous solutions using ascorbic acid
    Zaib, Qammer
    Park, Hung Suck
    Kyung, Daeseung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Hexavalent chromium reduction by gallic acid
    Mystrioti, Christiana
    Koursari, Stefania
    Xenidis, Anthimos
    Papassiopi, Nymphodora
    CHEMOSPHERE, 2021, 273
  • [24] REDUCTION OF GASTRIC CARCINOGENS WITH ASCORBIC-ACID
    RAINERI, R
    WEISBURGER, JH
    TRANSACTIONS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 36 (08): : 814 - 814
  • [25] THE REDUCTION OF IRON(III) BY ASCORBIC-ACID
    HYNES, MJ
    KELLY, DF
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1988, (13) : 849 - 850
  • [26] PROSTATE CARCINOGENESIS INVITRO - UNRESPONSIVENESS TO ASCORBIC-ACID
    BAL, E
    LUSTIG, ESD
    MEDICINA-BUENOS AIRES, 1976, 36 (01) : 23 - 28
  • [27] REDUCTION OF GASTRIC CARCINOGENS WITH ASCORBIC-ACID
    RAINERI, R
    WEISBURGER, JH
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1975, 258 (SEP30) : 181 - 189
  • [28] EFFECT OF ASCORBIC-ACID ON LIMB DEVELOPMENT INVITRO
    HARRISON, GE
    JOURNAL OF ANATOMY, 1979, 129 (DEC) : 850 - &
  • [29] EFFECTS OF ASCORBIC-ACID ON CHONDROCYTE PHENOTYPE INVITRO
    KEYES, S
    DANIEL, JC
    IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1981, 17 (03): : 251 - 251
  • [30] EFFECTS OF ASCORBIC-ACID ON HUMAN LYMPHOCYTES INVITRO
    FOGEL, JP
    SAMUELS, M
    SCHNEIDER, LK
    ANATOMICAL RECORD, 1975, 181 (02): : 357 - 357